Regeneron Ventures

cb Email

Status

ACTIVE

Global HQ

Tarrytown, United States

Countries of investment

United States
Canada
Norway

Investment stages

Seed
Series A

Industries

Biotech
Healthcare
AI

About
Regeneron Ventures is the strategic corporate venture capital fund of Regeneron. The firm invests in and supports innovative companies with disruptive technologies in the biopharmaceutical, healthcare, and health technology sectors. Their mission is to advance science and improve human health by leveraging Regeneron's extensive resources and expertise.

Min check size: $5M
Max check size: $50M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Regeneron Ventures is the corporate venture capital arm of Regeneron, investing in biopharmaceutical, healthcare, and health technology companies. They are stage-agnostic, seeking disruptive technologies with the potential to transform the practice of medicine and improve human health. Their unique value proposition is providing portfolio companies with access to Regeneron's deep scientific, clinical, and business expertise to accelerate growth and innovation.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

The leadership team, including the Head of Regeneron Ventures, brings extensive experience from senior roles in healthcare investment banking, venture capital, and corporate development at major firms like J.P. Morgan, T. Rowe Price, and Merck. The team combines deep scientific expertise with a strong track record in biopharmaceutical business development and strategic investment. Their collective background is rooted in identifying and nurturing early-stage companies with innovative technologies.